title: Transient leakage across the blood-cerebrospinal fluid barrier after intrathecal metrizamide administration to dogs.
abstract: Cerebrospinal fluid samples from 9 dogs given 84 mg of metrizamide/kg of body weight intrathecally were collected at intervals from 3 hours to 30 days after treatment and were compared with CSF samples collected before metrizamide treatment (base line) and with samples taken at similar intervals from 2 nontreated control dogs. Increased CSF albumin (mean 19.2 mg/dl) and immunoglobulin (Ig) G (mean 5.91 mg/dl) concentrations occurred 1 day after myelography, compared with base-line concentrations (6.15 and 1.24 mg/dl, respectively) and with concentrations from controls. Immunoglobulin M and IgA concentrations also were increased in some of these samples. However, immediately after myelography (3 hours after treatment) CSF albumin and IgG concentrations were comparable with those of controls, and these values returned to base line within 5 days of myelography and remained so for 30 days. A high correlation between albumin and IgG concentrations of individual CSF samples indicated the likelihood that leakage across the blood-CSF barrier was the origin of the increased values. A transient increase in CSF leukocytes, consisting of mononuclear cells and neutrophils, was also noticed 1 day after treatment but not at other times and not in controls. Nonsuppurative, predominately histiocytic meningitis of decreasing intensity was noticed in dogs euthanatized at 1 or 5 days, but not in dogs euthanatized at 10, 20, or 30 days after treatment. The meningeal cells stained intensely with periodic acid-Schiff stain and intracellular contrast medium was ultrastructurally apparent in phagolysosomes. Control dogs killed after 30 days did not have these changes. The intrathecal administration of metrizamide resulted in transient leakage of serum components into CSF and an accompanying transient meningitis.
mesh_terms: D000418:Albumins / Q000134:cerebrospinal fluid; D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002556:Cerebrospinal Fluid Proteins / Q000378:metabolism*; D004285:Dogs / Q000033:anatomy & histology / Q000134:cerebrospinal fluid*; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D007278:Injections, Spinal; D008578:Meninges / Q000187:drug effects / Q000648:ultrastructure; D008793:Metrizamide / Q000008:administration & dosage / Q000494:pharmacology*; D008854:Microscopy, Electron; D009192:Myelography / Q000662:veterinary
chemical_list: D000418:Albumins; D002556:Cerebrospinal Fluid Proteins; D007074:Immunoglobulin G; D008793:Metrizamide